BOSTON SCIENTIFIC CORPORATION Segment Reporting, Segment Revenue (Deprecated 2011-01-31)
BOSTON SCIENTIFIC CORPORATION (BSX) reported Segment Reporting, Segment Revenue (Deprecated 2011-01-31) of $1.88 billion for the 3-month period ending 2011-03-31, per its 10-Q filed 2011-05-05.
Discontinued › Income Statement › Other Income
us-gaap:SegmentReportingSegmentRevenue · last filed 2011-05-05
- BOSTON SCIENTIFIC CORPORATION segment reporting, segment revenue (deprecated 2011-01-31) for the quarter ending 2011-03-31 was $1.88B, a 0.69% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION segment reporting, segment revenue (deprecated 2011-01-31) for the quarter ending 2010-12-31 was $1.99B, a 3.59% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION segment reporting, segment revenue (deprecated 2011-01-31) for the quarter ending 2010-09-30 was $1.94B, a 5.05% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION segment reporting, segment revenue (deprecated 2011-01-31) for the quarter ending 2010-06-30 was $1.98B, a 7.04% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION segment reporting, segment revenue (deprecated 2011-01-31) for fiscal 2010 was $7.88B, a 5.25% decline from fiscal 2009.
- BOSTON SCIENTIFIC CORPORATION segment reporting, segment revenue (deprecated 2011-01-31) for fiscal 2009 was $8.32B, a 3.59% increase from fiscal 2008.
- BOSTON SCIENTIFIC CORPORATION segment reporting, segment revenue (deprecated 2011-01-31) for fiscal 2008 was $8.03B.
| Period end | Segment Reporting, Segment Revenue (Deprecated 2011-01-31) 3 month | Segment Reporting, Segment Revenue (Deprecated 2011-01-31) 6 month | Segment Reporting, Segment Revenue (Deprecated 2011-01-31) 9 month | Segment Reporting, Segment Revenue (Deprecated 2011-01-31) 12 month |
|---|---|---|---|---|
| 2011-03-31 | $1.88B 10-Q · filed 2011-05-05 | $3.86B derived: sum of 2 quarters · filed 2011-05-05 | $5.80B derived: sum of 3 quarters · filed 2011-05-05 | $7.78B derived: sum of 4 quarters · filed 2011-05-05 |
| 2010-12-31 | $1.99B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $3.92B derived: sum of 2 quarters · filed 2011-02-17 | $5.91B derived: sum of 3 quarters · filed 2011-02-17 | $7.88B 10-K · filed 2011-02-17 |
| 2010-09-30 | $1.94B 10-Q · filed 2010-11-05 | $3.92B derived: sum of 2 quarters · filed 2010-11-05 | $5.90B 10-Q · filed 2010-11-05 | $7.87B derived: sum of 4 quarters · filed 2011-05-05 |
| 2010-06-30 | $1.98B 10-Q · filed 2010-08-05 | $3.96B 10-Q · filed 2010-08-05 | $5.93B derived: sum of 3 quarters · filed 2011-05-05 | $7.97B derived: sum of 4 quarters · filed 2011-05-05 |
| 2010-03-31 | $1.89B 10-Q · filed 2011-05-05 | $3.95B derived: sum of 2 quarters · filed 2011-05-05 | $5.99B derived: sum of 3 quarters · filed 2011-05-05 | $8.12B derived: sum of 4 quarters · filed 2011-05-05 |
| 2009-12-31 | $2.06B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $4.10B derived: sum of 2 quarters · filed 2011-02-17 | $6.23B derived: sum of 3 quarters · filed 2011-02-17 | $8.32B 10-K · filed 2011-02-17 |
| 2009-09-30 | $2.04B 10-Q · filed 2010-11-05 | $4.17B derived: sum of 2 quarters · filed 2010-11-05 | $6.26B 10-Q · filed 2010-11-05 | |
| 2009-06-30 | $2.13B 10-Q · filed 2010-08-05 | $4.22B 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | $8.03B 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |